Joel S. Parker
Researcher Next ID · RN-020421
Researcher · Biochemistry, Genetics and Molecular Biology
University of North Carolina at Chapel Hill
Chapel Hill, Spain
- Works count
- 1,041
- Citation count
- 138,973
- H-index
- 138
- i10-index
- 340
Research interests
Publications
The Immune Landscape of Cancer
Immunity · 2019 · https://doi.org/10.1016/j.immuni.2019.08.004
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
JNCI Journal of the National Cancer Institute · 2019 · https://doi.org/10.1093/jnci/djz042
Integrated Molecular Characterization of Testicular Germ Cell Tumors
Cell Reports · 2018 · https://doi.org/10.1016/j.celrep.2018.05.039
Male breast cancer: a disease distinct from female breast cancer
Breast Cancer Research and Treatment · 2018 · https://doi.org/10.1007/s10549-018-4921-9
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Cell · 2017 · https://doi.org/10.1016/j.cell.2017.05.046
Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations
Nature Communications · 2017 · https://doi.org/10.1038/ncomms15290
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Proceedings of the National Academy of Sciences · 2014 · 10.1073/pnas.1318376111
Integrated genomic characterization of endometrial carcinoma
Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2013 · https://doi.org/10.1038/nature12113
Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
Breast Cancer Research and Treatment · 2011 · https://doi.org/10.1007/s10549-011-1846-y
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
Nature Biotechnology · 2010 · 10.1038/nbt.1665
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Clinical Cancer Research · 2010 · https://doi.org/10.1158/1078-0432.ccr-10-1282
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Breast Cancer Research · 2010 · https://doi.org/10.1186/bcr2635
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
JNCI Journal of the National Cancer Institute · 2009 · https://doi.org/10.1093/jnci/djp082
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2008.18.1370
RNA polymerase is poised for activation across the genome
Nature Genetics · 2007 · 10.1038/ng.2007.21
The molecular portraits of breast tumors are conserved across microarray platforms
BMC Genomics · 2006 · 10.1186/1471-2164-7-96
Extensive post-transcriptional regulation of microRNAs and its implications for cancer
Genes & Development · 2006 · 10.1101/gad.1444406
A custom microarray platform for analysis of microRNA gene expression
Nature Methods · 2004 · 10.1038/nmeth704
Repeated observation of breast tumor subtypes in independent gene expression data sets
Proceedings of the National Academy of Sciences · 2003 · https://doi.org/10.1073/pnas.0932692100
Current projects
No projects listed.